Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zebihair is a nutritional supplement developed by Resilient Cosmeceuticals, primarily indicated for the management of hair-related conditions such as telogen effluvium and premature hair greying. Formulated as an oral tablet, it contains a synergistic blend of essential vitamins, minerals, and amino acids, including biotin, calcium pantothenate, N-acetyl cysteine, zinc, selenium, and copper. These components work together to support the structural integrity of hair follicles, promote keratin synthesis, and provide antioxidant protection. Copper, specifically, acts as a cofactor for tyrosinase, the enzyme responsible for melanin production, thereby helping to maintain natural hair pigmentation and manage premature greying. The product is approved and marketed as a nutraceutical for hair health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zebihair.